[1. Van der Linden T, Souweine B, Dupic L, Soufir L, Meyer P. Management of thrombocytopenia in the ICU (pregnancy excluded) // Annals of intensive care 2012; 1:1-6]Search in Google Scholar
[2. Drews RE, Weinberger SE. Thrombocytopenic disorders in critically ill patients // Am J Respir Crit Care Med, 2000; 162:347-351]Search in Google Scholar
[3. Stephan F, Hollande J, Richard O. Thrombocytopenia in a surgical ICU // Chest, 1999; 115:1363-1370]Search in Google Scholar
[4. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit // Chest, 1993; 104:1243-1247]Search in Google Scholar
[5. Anis C, Fatma M, Kamilia S, Rania AC, Dammak H, Kallel H, Bahloul M, Bouaziz M. Thrombocytopenia in critically ill patients: A review of the literature // Trends in Anaesthesia and Critical Care, 2011; 4:199-202]Search in Google Scholar
[6. Akca S, Haji-Michael P, De Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients // Critical care medicine, 2002; 4:753-756]Search in Google Scholar
[7. Nijsten MW, ten Duis HJ, Zijlstra JG, Porte RJ, Zwaveling JH, Paling JC. Blunted rise in platelet count in critically ill patients is associated with worse outcome // Crit Care Med, 2000; 28:3843-3846]Search in Google Scholar
[8. Stéphan F, Hollande J, Richard O, Cheffi A, Maier- Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU // Chest, 1999; 115:1363-1370]Search in Google Scholar
[9. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopeniain patients in the medical intensive care unit: bleeding prevalence,transfusion requirements, and outcome // Crit Care Med, 2002; 30:1765-1771]Search in Google Scholar
[10. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care // Crit Care Med 2000; 28:1871-1876]Search in Google Scholar
[11. Brogly N, Devos P, Boussekey N, Georges H, Chiche A, Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia // Journal of Infection, 2007; 2:136-140]Search in Google Scholar
[12. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection // Heart & Lung: The Journal of Acute and Critical Care, 2010; 1:21-26]Search in Google Scholar
[13. Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome // Journal of Intensive Care, 2003; 1:9]Search in Google Scholar
[14. Neiderman MS, Community-acquired pneumonia // In: Vincent JL, Abraham E, Kochanek P, Moore FA, Fink MP. Textbook of critical care: expert consult premium. 6th ed. Philadelphia: Elsevier Saunders; 2011; 453-454]Search in Google Scholar
[15. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis // Jama, 1996; 2:134-141]Search in Google Scholar
[16. NICE clinical guideline 191: Pneumonia: Diagnosis and management of community- and hospitalacquired pneumonia in adults // National Institute for Health and Care Excellence, 2014. Reference from 03.03.2015. Available on the internet: https://www.nice.org.uk/guidance/cg191]Search in Google Scholar
[17. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Genin R, Yvin JL. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor // European Respiratory Journal 2004; 5:779-785]Search in Google Scholar
[18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis- Related Problems of the European Society of Intensive Care Medicine // Intensive Care Med, 1996: 22:707-1010.1007/BF017097518844239]Search in Google Scholar
[19. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, De Lassence A, Zahar JR, Adrie C. et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays // CHEST Journal, 2007; 6:1735-1741]Search in Google Scholar
[20. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne V. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor // The American journal of medicine, 1997; 2:114-120]Search in Google Scholar
[21. Levi M, Opal SM. Coagulation abnormalities in critically ill patients // Critical care, 2006; 4:222]Search in Google Scholar
[22. Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum // Nature Reviews Immunology, 2011; 4:264-274]Search in Google Scholar
[23. Speth C, Löffler J, Krappmann S, Lass-Flörl C, Rambach G. Platelets as immune cells in infectious diseases // Future microbiology, 2013; 11:1431-1451]Search in Google Scholar
[24. Visentin GP, Chao YL. Drug-induced thrombocytopenia // Hematology/oncology clinics of North America, 2007; 4:685-696]Search in Google Scholar
[25. Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Brunkhorst FM. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study // Crit Care, 2011; 15:88]Search in Google Scholar